##### 



Exhibit 12.1


CERTIFICATION PURSUANT TO SECTION 302


OF THE SARBANES-OXLEY ACT OF 2002






| |    |                                                                                                                                                                                                                                                                                                                           
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | 1. | I have reviewed this amended annual report on Form 20-F/A
    of Fresenius Medical Care Aktiengesellschaft (the
    Report).                                                                                                                                                                                            
|
| | 2. | Based on my knowledge, this Report does not contain any untrue
    statement of a material fact or omit to state a material fact
    necessary to make the statements made, in light of the
    circumstances under which such statements were made, not
    misleading with respect to the period covered by this Report.
|
| | 3. | Based on my knowledge, the financial statements, and other
    financial information included in this Report, fairly present in
    all material respects the financial condition, results of
    operations and cash flows of the company as of, and for, the
    periods presented in this Report.                      
|
| | 4. | The companys other certifying officer and I am responsible
    for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and
    15d-15(e)) for the company and have:                                                                                          



| |    |                                                                                                                                                                                                                                                                                                                                                                                                
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | a) | Designed such disclosure controls and procedures, or caused such
    disclosure controls and procedures to be designed under our
    supervision, to ensure that material information relating to the
    company, including its consolidated subsidiaries, is made known
    to us by others within those entities, particularly during the
    period in which this Report is being prepared;
|
| | b) | Evaluated the effectiveness of the companys disclosure
    controls and procedures and presented in this Report our
    conclusions about the effectiveness of the disclosure controls
    and procedures, as of the end of the period covered by this
    Report based on such evaluation; and                                                                                               
|
| | c) | Disclosed in this Report any change in the companys
    internal control over financial reporting that occurred during
    the period covered by the annual report that has materially
    affected, or is reasonably likely to materially affect, the
    companys internal control over financial reporting.                                                                               



| |    |                                                                                                                                                                                                                                                                                                       
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | 5. | The companys other certifying officer and I have
    disclosed, based on our most recent evaluation of internal
    control over financial reporting, to the companys auditors
    and the audit committee of the companys board of directors
    (or persons performing the equivalent functions):



| |    |                                                                                                                                                                                                                                                                                       
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | a) | All significant deficiencies and material weaknesses in the
    design or operation of internal control over financial reporting
    which are reasonably likely to adversely affect the
    companys ability to record, process, summarize and report
    financial information; and
|
| | b) | Any fraud, whether or not material, that involves management or
    other employees who have a significant role in the
    companys internal control over financial reporting.                                                                                                       





| |                                 
| | --------------------------------
| | /s/ Dr. Ben J. Lipps            
| |                                 
| | Dr. Ben J. Lipps                
| | Chief Executive Officer and     
| | Chairman of the Management Board